Draft Guidance for Industry; Availability: Chronic Hepatitis C Virus Infection; Developing Direct-Acting Antiviral Agents forTreatment
Title: Gilead Sciences Inc. - Comment
Gilead Sciences Inc. - Comment
This is comment on Notice
Draft Guidance for Industry; Availability: Chronic Hepatitis C Virus Infection; Developing Direct-Acting Antiviral Agents forTreatment
View Comment
Attachments:
Gilead Sciences Inc. - Comment
Title:
Gilead Sciences Inc. - Comment
Related Comments
View AllPublic Submission Posted: 11/18/2010 ID: FDA-2010-D-0462-0004
Nov 15,2010 11:59 PM ET
Public Submission Posted: 11/18/2010 ID: FDA-2010-D-0462-0006
Nov 15,2010 11:59 PM ET
Public Submission Posted: 11/18/2010 ID: FDA-2010-D-0462-0007
Nov 15,2010 11:59 PM ET
Public Submission Posted: 11/18/2010 ID: FDA-2010-D-0462-0008
Nov 15,2010 11:59 PM ET
Public Submission Posted: 11/18/2010 ID: FDA-2010-D-0462-0010
Nov 15,2010 11:59 PM ET